Quest Magazine

MDA Telethon Ends Historic Run, Urgent Fight for Families Continues

MDA is committed to accelerating treatments and cures,

using innovative ways to engage new supporters
 

Western Refining and MDA Join Forces to Help Send Kids with Muscle Disease to Summer Camp

Stores across the Southwest to raise vital funds through

MDA’s summer camp mobile program

 

BioMarin Completes Rolling NDA Submission for Treatment of Duchenne Muscular Dystrophy

MDA Adds Neurological Disease Expert to Research Team

Lianna R. Orlando, Ph.D of Harvard University named Scientific Program Officer

Lowe’s Reaches $50 Million Mark in Support of MDA

Stores Nationwide Raise More Than $7.5 Million during 2015
Shamrock Program to Help Improve Lives in MDA Communities

#MDAshamrocks

MDA Leader and Former National Ambassador Ben Cumbo Mourned by Muscular Dystrophy Community

MDA joins the larger disability community in mourning the loss of Benjamin Cumbo IV, who died yesterday at age 27.

Santhera Reports Positive Phase III Clinical Trial Results for Raxone®/Cantana® (idebenone) for the Treatment of Duchenne Muscular Dystrophy

MDA Families and Leadership Advocate in Washington, D.C.

BioBlast Pharma Receives FDA Fast Track Designation for Treatment of Oculopharyngeal Muscular Dystrophy

Santhera Receives FDA Fast Track Designation for Treatment of Duchenne Muscular Dystrophy

Pages